OutcomeRx Launches Innovative Targeted Stop-Loss Insurance Product Covering car T-Cell and Gene Therapies Business Wire (Press Release) 18:16 Tue, 12 May
Mirai Bio Presents Data Showing Rapid Advancement of Novel CD8+ T-Cell Targeted LNPs to Functional Nhp Proof-of-Concept at Asgct 2026 Business Wire (Press Release) 11:01 Tue, 12 May
Novel CAR T-Cell Therapies in MG May Require New Administration Protocols Rare Disease Advisor 22:09 Mon, 11 May
Women More Likely Than Men to Experience Toxicities From CAR T-Cell Therapy Oncology Nurse Advisor 14:41 Mon, 11 May
Comparing UV-enhanced and direct reduction strategies for CD8⁺ T-cell electrochemical detection Nature.com 04:33 Sat, 09 May
BioOra and Wellington Zhaotai Therapies to advance global expansion of CAR T-cell therapy BioSpectrum Asia 10:05 Thu, 07 May
BioOra Limited and Wellington Zhaotai Therapies Limited (WZTL) sign Heads of Terms to Advance their global expansion of CAR T-Cell Therapy PR Newswire (Press Release) 16:35 Wed, 06 May
Radboudumc gives first-ever experimental T-cell therapy to pancreatic cancer patient NL Times 15:18 Wed, 06 May
UCB Bets On T-Cell Engagers With $2.2bn Candid Acquisition Scrip Pharma Intelligence 13:02 Mon, 04 May
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease The Next Web 12:49 Mon, 04 May
Branched-chain amino acids ameliorate CD4+ T-cell-associated gut immune inflammation in Parkinson’s disease Nature.com 10:37 Mon, 04 May
UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers Business Wire (Press Release) 18:16 Sun, 03 May
Kernal Biologics to Showcase mRNA 2.0 Platform and T-Cell-Targeted LNPs for In Situ car T Programming at Asgct 2026 Business Wire (Press Release) 13:08 Thu, 30 Apr
TP53 Alterations Predict Poor Outcomes After CAR T-Cell Therapy Rare Disease Advisor 22:12 Tue, 28 Apr
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma PR Newswire (Press Release) 12:30 Tue, 28 Apr
Renal T-cell Profiles May Help Identify Lupus Nephritis Treatment Responders Renal and Urology News 14:21 Mon, 27 Apr
Excalipoint Therapeutics Launches with $68.7M to Develop Next-Gen T-Cell Engager Therapies in China BioSpectrum Asia 16:13 Sat, 25 Apr
SNUH–Stanford team clears key hurdle in T-cell lymphoma CAR-T Korea Biomedical Review 05:21 Fri, 24 Apr
A2 Biotherapeutics to Highlight Progress of car T-Cell Clinical Programs in Three Poster Presentations During the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting Business Wire (Press Release) 15:09 Wed, 22 Apr
AACR 2026:BCMA-directed CAR T-cell therapy may be effective against high-risk smouldering multiple myeloma ecancer 18:22 Tue, 21 Apr
Dana-Farber Phase 2 Trial Shows Deep and Lasting Responses to CAR T-Cell Therapy for High-Risk Smoldering Multiple Myeloma Newswise (Press Release) 18:34 Mon, 20 Apr
T-cell mesenchymal transition represents a potential pathogenic mechanism of female cancer-related lymphedema Nature.com 05:56 Mon, 20 Apr
CAR T-Cell Therapy Rese-Cel Depletes B Cells, With Early Signs of Clinical Benefit in MG Rare Disease Advisor 23:43 Thu, 16 Apr
Roswell Park Launches Exclusive CD83 CAR T-Cell Clinical Trial for Patients with Relapsed or Refractory AML Newswise (Press Release) 14:00 Tue, 14 Apr
Daily briefing: Car-T-cell therapy keeps a trio of autoimmune diseases at bay Nature.com 11:42 Tue, 14 Apr
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating Psma-targeted, pro-Xten® Dual-masked T-cell Engager Vir-5500 in Patients with Metastatic Prostate Cancer Business Wire (Press Release) 13:07 Mon, 13 Apr
